|2026年3月10日星期二| NO.1 和黄医药紧急宣布召回一款重磅肿瘤创新药 3月9日晚间,和黄医药公告称,其氢溴酸他泽司他片(商品名:达唯珂)的合作方益普生(Ipsen)已通知和黄医药正在美国自愿撤市该药,因此已采取措施在中国启动撤市及产品召回程序。和黄医药已随即启动在内地、香港和澳门撤市并召回该产品,并停止所有正在进行中的达唯珂的临床试验。 点评:因临床试验发现继发性血液恶性肿瘤...
Source Link|2026年3月10日星期二| NO.1 和黄医药紧急宣布召回一款重磅肿瘤创新药 3月9日晚间,和黄医药公告称,其氢溴酸他泽司他片(商品名:达唯珂)的合作方益普生(Ipsen)已通知和黄医药正在美国自愿撤市该药,因此已采取措施在中国启动撤市及产品召回程序。和黄医药已随即启动在内地、香港和澳门撤市并召回该产品,并停止所有正在进行中的达唯珂的临床试验。 点评:因临床试验发现继发性血液恶性肿瘤...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.